This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dr. Qureshi expands our understanding of the typical Medical Science Liaison role by taking a look at his position in managed markets. Great feature for those considering industry as a career option! Name: Nabeel Qureshi. Title: Medical Liaison, Managed Markets. Interview Summary. Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network.
Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.
I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found to have hydrochlorothiazide in his system. In clinical practice, for medical […].
The following case on methotrexate and thrombocytopenia was donated by Kirk Seale, M.S., PharmD, BCGP. Kirk received his Master’s degree in Drug regulatory affairs from the University of Florida and received his PharmD from the University of Mississippi. He has also been appointed to serve on the Government Affairs Committee with The American Society of Consultant […].
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content